| Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies A Agathangelidis, N Darzentas, A Hadzidimitriou, X Brochet, F Murray, ... Blood, The Journal of the American Society of Hematology 119 (19), 4467-4475, 2012 | 529 | 2012 |
| A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells L Eiselleova, K Matulka, V Kriz, M Kunova, Z Schmidtova, J Neradil, ... Stem cells 27 (8), 1847-1857, 2009 | 289 | 2009 |
| Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage J Malcikova, J Smardova, L Rocnova, B Tichy, P Kuglik, V Vranova, ... Blood, The Journal of the American Society of Hematology 114 (26), 5307-5314, 2009 | 273 | 2009 |
| miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities M Mráz, K Malinova, J Kotaskova, S Pavlova, B Tichy, J Malcikova, ... Leukemia 23 (6), 1159-1163, 2009 | 246 | 2009 |
| Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia J Malcikova, K Stano-Kozubik, B Tichy, B Kantorová, S Pavlova, N Tom, ... Leukemia 29 (4), 877-885, 2015 | 196 | 2015 |
| Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer M Svoboda, L Izakovicova Holla, R Sefr, I Vrtková, I Kocáková, B Tichy, ... International journal of oncology 33 (3), 541-547, 2008 | 149 | 2008 |
| The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration M Kaucká, K Plevová, Š Pavlová, P Janovská, A Mishra, J Verner, ... Cancer research 73 (5), 1491-1501, 2013 | 138 | 2013 |
| MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia M Mraz, D Dolezalova, K Plevova, K Stano Kozubik, V Mayerova, K Cerna, ... Blood, The Journal of the American Society of Hematology 119 (9), 2110-2113, 2012 | 121 | 2012 |
| Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity E Kostareli, M Gounari, A Janus, F Murray, X Brochet, V Giudicelli, ... Leukemia 26 (5), 1127-1131, 2012 | 86 | 2012 |
| Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status B Kubesova, S Pavlova, J Malcikova, J Kabáthová, L Radová, N Tom, ... Leukemia 32 (2), 450-461, 2018 | 74 | 2018 |
| High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene … J Kotaskova, B Tichy, M Trbusek, HS Francova, J Kabathova, J Malcikova, ... The Journal of Molecular Diagnostics 12 (3), 328-334, 2010 | 69 | 2010 |
| Micro RNA and mesial temporal lobe epilepsy with hippocampal sclerosis: whole mi RN ome profiling of human hippocampus P Bencurova, J Baloun, K Musilova, L Radova, B Tichy, M Pail, M Zeman, ... Epilepsia 58 (10), 1782-1793, 2017 | 58 | 2017 |
| Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clones K Plevova, HS Francova, K Burckova, Y Brychtova, M Doubek, S Pavlova, ... Haematologica 99 (2), 329, 2014 | 55 | 2014 |
| Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1 V Khare, A Lyakhovich, K Dammann, M Lang, M Borgmann, B Tichy, ... Biochemical pharmacology 85 (2), 234-244, 2013 | 54 | 2013 |
| Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options J Malcikova, S Pavlova, B Kunt Vonkova, L Radova, K Plevova, ... Blood, The Journal of the American Society of Hematology 138 (25), 2670-2685, 2021 | 52 | 2021 |
| STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma C Lobello, B Tichy, V Bystry, L Radova, D Filip, M Mraz, ... Leukemia 35 (5), 1500-1505, 2021 | 46 | 2021 |
| KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis T Limberger, M Schlederer, K Trachtová, I Garces de los Fayos Alonso, ... Molecular Cancer 21 (1), 89, 2022 | 33 | 2022 |
| Trypanosomatid mitochondrial RNA editing: dramatically complex transcript repertoires revealed with a dedicated mapping tool ES Gerasimov, AA Gasparyan, I Kaurov, B Tichý, MD Logacheva, ... Nucleic acids research 46 (2), 765-781, 2018 | 32 | 2018 |
| Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8‐color flow cytometry protocol in routine hematological practice O Stehlíková, J Chovancová, B Tichý, M Krejčí, Y Brychtová, A Panovská, ... International journal of laboratory hematology 36 (2), 165-171, 2014 | 30 | 2014 |
| The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus M Mraz, KS Kozubik, K Plevova, K Musilova, B Tichy, M Borsky, P Kuglik, ... Leukemia research 37 (7), 802-808, 2013 | 27 | 2013 |
